Skip to main content
TipRanks
Go Ultimate75% OFF

Alzamend Neuro (9ZT) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

Alzamend Neuro has a market cap or net worth of EUR 5.43M. The enterprise value is EUR 1.21T.

Market Cap
EUR 5.43M
Enterprise Value
EUR 1.21T

Share Statistics

Alzamend Neuro has 4,825,723 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
4,825,723
Owned by Insiders
2.65%
Owned by Institutions
24.74%

Financial Efficiency

Alzamend Neuro’s return on equity (ROE) is -11.96 and return on invested capital (ROIC) is -1195.68%.

Return on Equity (ROE)
-11.96
Return on Assets (ROA)
-4.22
Return on Invested Capital (ROIC)
-1195.68%
Return on Capital Employed (ROCE)
-11.96
Revenue Per Employee
0
Profits Per Employee
-1.46M
Employee Count
6
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Alzamend Neuro is -0.50. Alzamend Neuro’s PEG ratio is -0.00.

PE Ratio
-0.50
PS Ratio
0.00
PB Ratio
0.88
Price to FCF
-0.80
Price to Operating Cash Flow
-0.75
PEG Ratio
-0.00

Income Statement

In the last 12 months, Alzamend Neuro had revenue of 0 and earned -8.77M in profits. Earnings per share was -2.63.

Revenue
0
Gross Profit
0
Operating Income
-8.77M
Pretax Income
-8.77M
Net Income
-8.77M
EBITDA
-8.66M
Earnings Per Share (EPS)
-2.63

Cash Flow

In the last 12 months, operating cash flow was -6.84M and capital expenditures 0, giving a free cash flow of -6.84M billion.

Operating Cash Flow
-6.84M
Free Cash Flow
-6.84M
Free Cash Flow per Share
-1.53

Dividends & Yields

Alzamend Neuro pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-120.18%
Earnings Yield
-172.13%

Stock Price Statistics

Beta
0.00
52-Week Price Change
0.00%
50-Day Moving Average
194.40
200-Day Moving Average
194.40
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Important Dates

Alzamend Neuro upcoming earnings date is ―, Before Open (Confirmed).

Last Earnings Date
Mar 16, 2023
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

Alzamend Neuro as a current ratio of 1.31, with Debt / Equity ratio of 0.00%

Current Ratio
1.31
Quick Ratio
1.31
Debt to Market Cap
0.00
Net Debt to EBITDA
0.08
Interest Coverage Ratio
1324.50

Taxes

In the past 12 months, Alzamend Neuro has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Alzamend Neuro EV to EBITDA ratio is 0.21, with an EV/FCF ratio of 0.28.

EV to Sales
0.00
EV to EBITDA
0.21
EV to Free Cash Flow
0.28
EV to Operating Cash Flow
0.28

Balance Sheet

Alzamend Neuro has EUR 7.59M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 7.59M billion.

Cash & Marketable Securities
EUR 7.59M
Total Debt
EUR 0.00
Net Cash
EUR 7.59M
Net Cash Per Share
EUR 1.57
Tangible Book Value Per Share
EUR 1.30

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Alzamend Neuro is EUR 23.32, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
EUR 23.32
Price Target Upside
88.01% Downside
Analyst Consensus
Moderate Buy
Analyst Count
1
Revenue Growth Forecast
―
EPS Growth Forecast
―